Biogen Inc. today announced the European Commission (EC) has granted marketing authorization for a high dose regimen of SPINRAZA® (nusinersen) which is comprised of 50 mg/5 mL and 28 mg/5 mL doses for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback